Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.102EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.102EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.102ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.102ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.102EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.102EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.102ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.102ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FK.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FK.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FK.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FK.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FK.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FK.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GN.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GN.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GN.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GN.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GN.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GN.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GN.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GN.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.31EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.31ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.31ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.31EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.31EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.13.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.13.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.13.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.13.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.13.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.13.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.13.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.61EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.61ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.61ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.61EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.61EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.61ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.61ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FR.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FR.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used